Rossari Biotech (NSE:ROSSARI) Beneish M-Score: -2.05 (As of Jun. 26, 2026)


NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
85 GF Score
Price ₹534.85
GF Value ₹998.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Beneish M-Score?

Rossari Biotech NSE:ROSSARI -0.48% 85 Beneish M-Score is -2.05 as of Jun. 26, 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹998.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,530 Chemicals companies, Rossari Biotech ranks worse than 77.39% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.05 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Rossari Biotech's Beneish M-Score or its related term are showing as below:

NSE:ROSSARI' s Beneish M-Score Range Over the Past 10 Years
Min: -2.7   Med: -2.08   Max: 0.03
Current: -2.05

During the past 9 years, the highest Beneish M-Score of Rossari Biotech was 0.03. The lowest was -2.70. And the median was -2.08.


Rossari Biotech Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech Beneish M-Score Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only 0.03 -2.70 -2.08 -2.59 -2.05

Rossari Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.59 0.00 0.00 0.00 -2.05

NSE:ROSSARI vs LIN, SHW, ECL: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, Rossari Biotech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rossari Biotech Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Rossari Biotech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rossari Biotech's Beneish M-Score falls into.


NSE:ROSSARI
85GF Score
Rossari Biotech Ltd NSE:ROSSARI
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rossari Biotech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0186+0.528 * 1.0243+0.404 * 0.8854+0.892 * 1.1519+0.115 * 1.1065
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.036764-0.327 * 1.1368
=-2.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹5,586 Mil.
Revenue was ₹23,964 Mil.
Gross Profit was ₹7,276 Mil.
Total Current Assets was ₹12,359 Mil.
Total Assets was ₹22,888 Mil.
Property, Plant and Equipment(Net PPE) was ₹7,338 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹791 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹7,896 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,146 Mil.
Net Income was ₹1,492 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹651 Mil.
Total Receivables was ₹4,760 Mil.
Revenue was ₹20,803 Mil.
Gross Profit was ₹6,470 Mil.
Total Current Assets was ₹10,419 Mil.
Total Assets was ₹18,962 Mil.
Property, Plant and Equipment(Net PPE) was ₹5,557 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹671 Mil.
Selling, General, & Admin. Expense(SGA) was ₹1,228 Mil.
Total Current Liabilities was ₹5,366 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1,223 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5585.66 / 23963.65) / (4760.29 / 20802.94)
=0.233089 / 0.228828
=1.0186

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6469.97 / 20802.94) / (7276.38 / 23963.65)
=0.311012 / 0.303642
=1.0243

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12359 + 7338.39) / 22887.92) / (1 - (10419.27 + 5557.25) / 18961.84)
=0.139398 / 0.157438
=0.8854

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=23963.65 / 20802.94
=1.1519

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(670.73 / (670.73 + 5557.25)) / (791.24 / (791.24 + 7338.39))
=0.107696 / 0.097328
=1.1065

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 23963.65) / (1227.69 / 20802.94)
=0 / 0.059015
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1145.79 + 7895.58) / 22887.92) / ((1223.39 + 5365.72) / 18961.84)
=0.395028 / 0.347493
=1.1368

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1492.13 - 0 - 650.68) / 22887.92
=0.036764

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rossari Biotech has a M-score of -2.05 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.05 mean?
Rossari Biotech (NSE:ROSSARI) has a Beneish M-Score of -2.05 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rossari Biotech and its competitors. According to the industry distribution chart, Rossari Biotech ranks #1184 out of 1530 companies in the Chemicals industry, placing it in the top 77.4%.
Is Rossari Biotech's Beneish M-Score too high?
Rossari Biotech's current Beneish M-Score is -2.05. Based on the distribution chart, Rossari Biotech ranks #1184 out of 1530 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Beneish M-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #1184 out of 1530 companies for Beneish M-Score. This places Rossari Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current Beneish M-Score is -2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.23, compared to a current price of ₹534.85 — trading 46.4% below its estimated fair value. The current Beneish M-Score is -2.05. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Beneish M-Score is -2.05 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • Beneish M-Score: -2.05
  • GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score

Get the complete analysis for NSE:ROSSARI

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹534.85
Price
₹998.23
GF Value